Abreos Biosciences Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Abreos Biosciences Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10362
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abreos Biosciences Inc (Abreos) is a biotechnology company with focus on the development of laboratory-based and point-of-care (POC) assays and reagents for the precision dose monitoring of biologic drugs. Its Monator, is a drug-monitoring test that provides physicians with vital information for the personalized treatment of multiple sclerosis using natalizumab. The company developed a veritope technology platform to identify proprietary peptide-based ligands that can measure and purify biologic molecules. Its Veritopes can be customized for use in multiple formats including sandwich ELISA for the direct tracking of blood concentrations of biologic drugs. Abreos offers custom reagents to biopharmaceutical manufacturers and researchers for drug development life cycle; pharmacokinetic studies; bio-purification; and personalized dosing of biologic drugs. Abreos is headquartered in San Diego, California, the US.

Abreos Biosciences Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Abreos Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abreos Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Abreos Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abreos Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Abreos Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Abreos Biosciences Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Abreos Biosciences Raises USD1.2 Million in Financing 10
Abreos Biosciences Raises USD0.1 Million in Venture Financing 11
Abreos Biosciences Raises USD0.7 Million in Seed Financing 12
Abreos Biosciences Raises USD0.2 Million in Venture Financing 13
Partnerships 14
Abreos Biosciences and Institut Paoli-Calmettes Enter into Research Collaboration 14
Abreos Biosciences Enters into Co-Development Agreement with True Diagnostics 15
Abreos Biosciences Inc – Key Competitors 16
Abreos Biosciences Inc – Key Employees 17
Abreos Biosciences Inc – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
Jan 24, 2018: Abreos Biosciences Wins Promising Company Award at the Precision Medicine World Conference 2018 19
Sep 26, 2017: Abreos Biosciences competed as a finalist in the MedTech Innovator 2017 Competition 20
Government and Public Interest 22
May 31, 2017: MedTech Innovator Announces Startups Selected for Industry’s Premier Accelerator 22
Other Significant Developments 23
Jun 20, 2018: Abreos Biosciences and LifeAssays sign R & D agreements for cancer and autoimmune tests in human medicine 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
Abreos Biosciences Inc, Medical Equipment, Key Facts 2
Abreos Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Abreos Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abreos Biosciences Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Abreos Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abreos Biosciences Inc, Deals By Market, 2012 to YTD 2018 8
Abreos Biosciences Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Abreos Biosciences Raises USD1.2 Million in Financing 10
Abreos Biosciences Raises USD0.1 Million in Venture Financing 11
Abreos Biosciences Raises USD0.7 Million in Seed Financing 12
Abreos Biosciences Raises USD0.2 Million in Venture Financing 13
Abreos Biosciences and Institut Paoli-Calmettes Enter into Research Collaboration 14
Abreos Biosciences Enters into Co-Development Agreement with True Diagnostics 15
Abreos Biosciences Inc, Key Competitors 16
Abreos Biosciences Inc, Key Employees 17

List of Figures
Abreos Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Abreos Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Abreos Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Abreos Biosciences Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Abreos Biosciences Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Abreos Biosciences Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Abreos Biosciences Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Abreos Biosciences Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Abreos Biosciences Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Neos Therapeutics Inc (NEOS):製薬・医療:M&Aディール及び事業提携情報
    Summary Neos Therapeutics Inc (Neos Therapeutics), formerly Neostx Inc, develops, manufactures, and commercializes branded pharmaceuticals. The company’s portfolio includes Adzenys XR-ODT that is indicated for the treatment of attention deficit hyperactivity disorder (ADHD) in patients of six years …
  • J.W. Ostendorf Gmbh & Co Kg:企業の戦略・SWOT・財務分析
    J.W. Ostendorf Gmbh & Co Kg - Strategy, SWOT and Corporate Finance Report Summary J.W. Ostendorf Gmbh & Co Kg - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • EryDel SPA:製薬・医療:M&Aディール及び事業提携情報
    Summary EryDel SPA (EryDel), a subsidiary of Genextra Spa is a drug delivery company that develops drugs and diagnostics delivered through human red blood cells using a proprietary medical device technology. The company’s products include red cell loaders, and disposable kits for drug encapsulation …
  • Kot Addu Power Co Ltd:発電所・企業SWOT分析
    Kot Addu Power Co Ltd - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employe …
  • Fossil Group, Inc. (FOSL):企業の財務・戦略的SWOT分析
    Fossil Group, Inc. (FOSL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • EQT Corp (EQT):企業の財務・戦略的SWOT分析
    EQT Corp (EQT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Tech Mahindra Limited (TECHM):企業の財務・戦略的SWOT分析
    Tech Mahindra Limited (TECHM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • H.B. Fuller Co (FUL):企業の財務・戦略的SWOT分析
    H.B. Fuller Co (FUL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • FP Corporation:企業の戦略・SWOT・財務情報
    FP Corporation - Strategy, SWOT and Corporate Finance Report Summary FP Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • TDC A/S:企業の戦略・SWOT・財務分析
    TDC A/S - Strategy, SWOT and Corporate Finance Report Summary TDC A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Global Telecom Holding SAE:企業の戦略的SWOT分析
    Global Telecom Holding SAE - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Mapletree Greater China Commercial Trust Management Ltd:企業の戦略・SWOT・財務情報
    Mapletree Greater China Commercial Trust Management Ltd - Strategy, SWOT and Corporate Finance Report Summary Mapletree Greater China Commercial Trust Management Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the compan …
  • DLF Ltd:企業の戦略・SWOT・財務分析
    DLF Ltd - Strategy, SWOT and Corporate Finance Report Summary DLF Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Red Electrica Corporacion SA (REE):電力:M&Aディール及び事業提携情報
    Summary Red Electrica Corporacion SA (REC), together with its subsidiaries undertakes electricity transmission and system operation and management of the transmission network for the Spanish electricity system. The company carries out the regulated activities through its principal subsidiary, Red El …
  • NovaMedica LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary NovaMedica LLC (NovaMedica) is a pharmaceutical company that develops drugs for various therapeutic areas. The company offers drugs in the areas of cardiovascular, central nervous system, dermatology, endocrinology, gynecology, infectious disease, gastrointestinal, pediatric, woman’s health, …
  • Meritor, Inc. (MTOR):企業の財務・戦略的SWOT分析
    Meritor, Inc. (MTOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • ShinMaywa Industries, Ltd.:企業の戦略・SWOT・財務情報
    ShinMaywa Industries, Ltd. - Strategy, SWOT and Corporate Finance Report Summary ShinMaywa Industries, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Aravive Inc (VSAR):企業の財務・戦略的SWOT分析
    Summary Aravive Inc(Aravive) formerly known as Versartis Inc, is a biopharmaceutical company that develops, manufactures and commercializes medicines for the treatment of endocrine disorders. The company’s lead product candidate include somavaratan (VRS-317) is a recombinant human growth hormone (GH …
  • Levi Strauss & Co:企業の戦略的SWOT分析
    Levi Strauss & Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • American Overseas Group Limited
    American Overseas Group Limited - Strategy, SWOT and Corporate Finance Report Summary American Overseas Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆